Tolerability of Oral Dextromethorphan in Patients with a History of Brain Ischemia
- 1 December 1992
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Clinical Neuropharmacology
- Vol. 15 (6) , 509-514
- https://doi.org/10.1097/00002826-199212000-00009
Abstract
Twelve patients with a history of cerebral ischemia were randomized to treatment with the N-methyl-D-aspartate antagonist dextromethorphan (60 or 90 mg p.o. q.i.d.) or placebo for 2 weeks in a randomized, safety study. Neuropsychological testing did not detect evidence of cognitive dysfunction; however, side effects including lightheadedness, drowsiness, nausea, decreased coordination, and unsteady gait were reported by several patients while taking dextromethorphan.Keywords
This publication has 0 references indexed in Scilit: